Tokman Alexander Y 4
4 · ENDRA Life Sciences Inc. · Filed Mar 25, 2021
Insider Transaction Report
Form 4
Tokman Alexander Y
DirectorChief Executive Officer
Transactions
- Award
Stock Options
[F1]2021-01-04+12,000→ 12,000 totalExercise: $0.80From: 2022-01-04Exp: 2031-01-04→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]Represents a stock option award granted on January 4, 2021 pursuant to the Issuer's Non-Employee Director Compensation Policy.
Signature
/s/ Alexander Y. Tokman by Mark R. Busch, attorney-in-fact|2021-03-25